Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AXSM

Axsome Therapeutics Inc

May 29 • 04:00PM ET

234.48

+1.65 0.71 %

Healthcare • Biotechnology • USA • Large • NASD

Peers: JAZZ BMRN IONS ALNY BBIO EXEL INCY MDGL NBIX VRTX

| Held by: VTI IWM VB VBK FBT VXF IWO IBB SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.74	Insider Own	16.33%	Shs Outstand	51.42M	Perf Week	0.36%
Market Cap	12.07B	Forward P/E	40.58	EPS next Y	5.78	Insider Trans	-4.34%	Shs Float	43.06M	Perf Month	27.47%
Enterprise Value	11.98B	PEG	-	EPS next Q	-0.84	Inst Own	74.90%	Short Float	6.45%	Perf Quarter	43.07%
Income	-188.30M	P/S	17.04	EPS this Y	46.68%	Inst Trans	0.75%	Short Ratio	4.01	Perf Half Y	55.95%
Sales	708.24M	P/B	220.88	EPS next Y	394.48%	ROA	-28.74%	Short Interest	2.78M	Perf YTD	28.38%
Book/sh	1.06	P/C	39.55	EPS next 5Y	-	ROE	-349.38%	52W High	238.56 -1.71%	Perf Year	124.08%
Cash/sh	5.93	P/FCF	-	EPS past 3/5Y	7.17% -5.89%	ROIC	-93.84%	52W Low	96.09 144.02%	Perf 3Y	235.93%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	133.68% -	Gross Margin	91.30%	Volatility	2.36% 4.30%	Perf 5Y	286.23%
Dividend TTM	-	EV/Sales	16.92	EPS Y/Y TTM	35.18%	Oper. Margin	-24.93%	ATR (14)	7.52	Perf 10Y	2823.69%
Dividend Ex-Date	-	Quick Ratio	1.32	Sales Y/Y TTM	63.88%	Profit Margin	-26.59%	RSI (14)	69.59	Recom	1.24
Dividend Gr. 3/5Y	- -	Current Ratio	1.39	EPS Q/Q	-3.69%	SMA20	3.30%	Beta	0.60	Target Price	270.89
Payout	-	Debt/Eq	4.03	Sales Q/Q	57.42%	SMA50	19.60%	Rel Volume	1.32	Prev Close	232.83
Employees	925	LT Debt/Eq	2.68	Earnings	May 04 BMO	SMA200	47.20%	Avg Volume	693.09K	Price	234.48
IPO	Nov 19, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-49.22% -0.79%	Trades		Volume	912,091	Change	0.71%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)